Q2 2018 13F Holders as of 6/30/2018
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
112M
-
Number of holders
-
158
-
Total 13F shares, excl. options
-
51.8M
-
Shares change
-
+8.6M
-
Total reported value, excl. options
-
$1.62B
-
Value change
-
+$283M
-
Put/Call ratio
-
0.23
-
Number of buys
-
111
-
Number of sells
-
-46
-
Price
-
$31.30
Significant Holders of NovoCure Ltd - Common Stock (NVCR) as of Q2 2018
188 filings reported holding NVCR - NovoCure Ltd - Common Stock as of Q2 2018.
NovoCure Ltd - Common Stock (NVCR) has 158 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 51.8M shares
of 112M outstanding shares and own 46.25% of the company stock.
Largest 10 shareholders include FMR LLC (7.86M shares), VANGUARD GROUP INC (4.95M shares), BlackRock Inc. (4.62M shares), BAILLIE GIFFORD & CO (3.09M shares), Capital World Investors (1.88M shares), FARALLON CAPITAL MANAGEMENT LLC (1.59M shares), TimesSquare Capital Management, LLC (1.49M shares), STATE STREET CORP (1.32M shares), WADDELL & REED FINANCIAL INC (1.27M shares), and PEREGRINE CAPITAL MANAGEMENT LLC (871K shares).
This table shows the top 158 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.